EW vs. NVNO

Last updated Apr 2, 2026

Compare and contrast key facts about Edwards Lifesciences Corporation (EW) and enVVeno Medical Corporation (NVNO).

Performance

EW vs. NVNO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edwards Lifesciences Corporation (EW) and enVVeno Medical Corporation (NVNO). The values are adjusted to include any dividend payments, if applicable.

EW vs. NVNO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
EW Edwards Lifesciences Corporation	-4.68%	15.16%	-2.91%	2.20%	-42.41%	42.00%	17.32%	52.31%	11.55%
NVNO enVVeno Medical Corporation	-8.27%	-89.38%	-41.25%	0.78%	-22.61%	-23.82%	-37.09%	-62.71%	-71.85%

Fundamentals

Market Cap EW : $47.28B NVNO : $6.07M
EPS EW : $1.83 NVNO : -$93.91
PB Ratio EW : 4.57 NVNO : 0.22
Total Revenue (TTM) EW : $6.07B NVNO : $0.00
Gross Profit (TTM) EW : $4.74B NVNO : -$372.00K
EBITDA (TTM) EW : $1.35B NVNO : -$19.38M

Returns By Period

In the year-to-date period, EW achieves a -4.68% return, which is significantly higher than NVNO's -8.27% return.

EW

• 1D: 1.47%
• 1M: -6.79%
• YTD: -4.68%
• 6M: 6.49%
• 1Y: 13.07%
• 3Y*: -0.60%
• 5Y*: -0.62%
• 10Y*: 10.49%

NVNO

• 1D: 1.68%
• 1M: 1.08%
• YTD: -8.27%
• 6M: -67.68%
• 1Y: -88.46%
• 3Y*: -60.23%
• 5Y*: -46.65%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

EW vs. NVNO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EW

EW Risk / Return Rank: 58
EW Sharpe Ratio Rank: 60
EW Sortino Ratio Rank: 54
EW Omega Ratio Rank: 51
EW Calmar Ratio Rank: 62
EW Martin Ratio Rank: 65

NVNO

NVNO Risk / Return Rank: 10
NVNO Sharpe Ratio Rank: 10
NVNO Sortino Ratio Rank: 9
NVNO Omega Ratio Rank: 7
NVNO Calmar Ratio Rank: 5
NVNO Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EW vs. NVNO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and enVVeno Medical Corporation (NVNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	EW	NVNO	Difference
Sharpe ratio Return per unit of total volatility	0.55	-0.73	+1.27
Sortino ratio Return per unit of downside risk	0.98	-1.09	+2.07
Omega ratio Gain probability vs. loss probability	1.11	0.83	+0.29
Calmar ratio Return relative to maximum drawdown	0.95	-0.93	+1.88
Martin ratio Return relative to average drawdown	2.63	-1.25	+3.88
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

EW vs. NVNO - Sharpe Ratio Comparison

The current EW Sharpe Ratio is 0.55, which is higher than the NVNO Sharpe Ratio of -0.73. The chart below compares the historical Sharpe Ratios of EW and NVNO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	EW	NVNO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.55	-0.73	+1.27
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.02	-0.58	+0.56
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.32	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.51	-0.57	+1.09

Correlation

The correlation between EW and NVNO is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

EW vs. NVNO - Dividend Comparison

Neither EW nor NVNO has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

EW vs. NVNO - Drawdown Comparison

The maximum EW drawdown since its inception was -54.32%, smaller than the maximum NVNO drawdown of -99.81%. Use the drawdown chart below to compare losses from any high point for EW and NVNO.

Drawdown Indicators

	EW	NVNO	Difference
Max Drawdown Largest peak-to-trough decline	-54.32%	-99.81%	+45.49%
Max Drawdown (1Y) Largest decline over 1 year	-12.73%	-95.28%	+82.55%
Max Drawdown (5Y) Largest decline over 5 years	-54.32%	-97.66%	+43.34%
Max Drawdown (10Y) Largest decline over 10 years	-54.32%	—	—
Current Drawdown Current decline from peak	-37.82%	-99.78%	+61.96%
Average Drawdown Average peak-to-trough decline	-14.31%	-89.75%	+75.44%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.61%	70.94%	-66.33%

Volatility

EW vs. NVNO - Volatility Comparison

The current volatility for Edwards Lifesciences Corporation (EW) is 7.95%, while enVVeno Medical Corporation (NVNO) has a volatility of 24.63%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than NVNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	EW	NVNO	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.95%	24.63%	-16.68%
Volatility (6M) Calculated over the trailing 6-month period	17.43%	81.30%	-63.87%
Volatility (1Y) Calculated over the trailing 1-year period	24.02%	121.78%	-97.76%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.49%	81.30%	-48.81%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.59%	94.32%	-61.73%

Financials